RecruitingNot ApplicableNCT05062252

Mirror Medacta Shoulder System Pivotal Trial

Multicentric, Prospective, Comparative Trial to Assess the Efficacy and Safety of an Anatomic Total Shoulder System.

Sponsor

Medacta International SA

Enrollment

100 participants

Start Date

Jan 5, 2022

Study Type

INTERVENTIONAL

Conditions

Arthritis Shoulder Post-traumatic Arthrosis of Other Joints, Upper Arm

Summary

The purpose of this study is to demonstrate safety and efficacy of the Mirror Medacta Shoulder System in total shoulder arthroplasty.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Medacta Shoulder System and a medical device called Mirror Medacta Shoulder System for people with arthritis shoulder and post-traumatic arthrosis of other joints, upper arm. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMirror Medacta Shoulder System

Anatomic total shoulder arthroplasty system

DEVICEMedacta Shoulder System

Anatomic total shoulder arthroplasty system - standard configuration

Locations(2)

Lindenhofgruppe AG - Orthopädie Sonnenhof

Bern, Switzerland

Klinik für Orthopädische Chirurgie und Traumatologie des Bewegungsapparates, Kantonsspital St.Gallen

Sankt Gallen, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05062252

Related Trials

Efficacy of Intra-articular Injections for the Treatment of Primary Glenohumeral Osteoarthritis(GHOA)

NCT049490871 location